PD-1 inhibitor plus chemotherapy (neoadjuvant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 inhibitor plus chemotherapy (neoadjuvant), covering 2025-04-30 to 2025-04-30. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma [Phase 2]